Skip to main content

Research Repository

Advanced Search

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention

Li, Tiantian; Lu, Li; Pember, Eloise; Li, Xinuo; Zhang, Bocheng; Zhu, Zheying

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention Thumbnail


Authors

Tiantian Li

LI LU Li.Lu1@nottingham.ac.uk
Research Associate

Eloise Pember

Xinuo Li

Bocheng Zhang

ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
Associate Professor in International Pharmacy and Traditional Medicines



Abstract

Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 50 million people worldwide with an estimated increase to 139 million people by 2050. The exact pathogenic mechanisms of AD remain elusive, resulting in the fact that the current therapeutics solely focus on symptomatic management instead of preventative or curative strategies. The two most widely accepted pathogenic mechanisms of AD include the amyloid and tau hypotheses. However, it is evident that these hypotheses cannot fully explain neuronal degeneration shown in AD. Substantial evidence is growing for the vital role of neuroinflammation in AD pathology. The neuroinflammatory hypothesis provides a new, exciting lead in uncovering the underlying mechanisms contributing to AD. This review aims to highlight new insights into the role of neuroinflammation in the pathogenesis of AD, mainly including the involvement of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB), nucleotide-binding oligomerization domain, leucine‐rich repeat‐containing protein 3 (NLRP3)/caspase‐1 axis, triggering receptor expressed on myeloid cells 2 (TREM2) and cGAS‐STING as key influencers in augmenting AD development. The inflammasomes related to the pathways of NF‐κB, NLRP3, TREM2, and cGAS‐STING as biomarkers of the neuroinflammation associated with AD, as well as an overview of novel AD treatments based on these biomarkers as potential drug targets reported in the literature or under clinical trials, are explored.

Citation

Li, T., Lu, L., Pember, E., Li, X., Zhang, B., & Zhu, Z. (2022). New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention. Cells, 11(12), Article 1925. https://doi.org/10.3390/cells11121925

Journal Article Type Article
Acceptance Date Jun 11, 2022
Online Publication Date Jun 14, 2022
Publication Date Jun 1, 2022
Deposit Date Jun 18, 2022
Publicly Available Date Jun 21, 2022
Journal Cells
Electronic ISSN 2073-4409
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 11
Issue 12
Article Number 1925
DOI https://doi.org/10.3390/cells11121925
Public URL https://nottingham-repository.worktribe.com/output/8501824
Publisher URL https://www.mdpi.com/2073-4409/11/12/1925

Files





You might also like



Downloadable Citations